Your search returned 12 results.

Results
	1.	Prevention of vascular events in patients with cerebrovascular disease: efficacy and appropriate duration of antiplatelet therapy. [electronic resource] by Habib, Gabriel B Producer: 20061010 In: Clinical cardiology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper. [electronic resource] by Habib, Gabriel B Basra, Sukhdeep S Producer: 20150701 In: Journal of cardiovascular pharmacology and therapeutics vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Is 2015 the primetime year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker? [electronic resource] by Habib, Gabriel B Virani, Salim S Jneid, Hani Producer: 20151030 In: Journal of the American Heart Association vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Herpes zoster and its cardiovascular complications in the elderly--another look at a dormant virus. [electronic resource] by Ma, Tony S Collins, Tracie C Habib, Gabriel Bredikis, Audrius Carabello, Blase A Producer: 20070315 In: Cardiology vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. [electronic resource] by Dhaliwal, Amandeep Singh Bredikis, Audrius Habib, Gabriel Carabello, Blase Anthony Ramasubbu, Kumudha Bozkurt, Biykem Producer: 20081204 In: The American journal of cardiology vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. [electronic resource] by Dhaliwal, Amandeep S Habib, Gabriel Deswal, Anita Verduzco, Melinda Souchek, Julianne Ramasubbu, Kumudha Aguilar, David Ma, Tony S Jneid, Hani M Bolos, Mariana Bozkurt, Biykem Producer: 20090721 In: The American journal of cardiology vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. [electronic resource] by Barzilay, Joshua I Davis, Barry R Bettencourt, Judy Margolis, Karen L Goff, David C Black, Henry Habib, Gabriel Ellsworth, Allan Force, Rex W Wiegmann, Thomas Ciocon, Jerry O Basile, Jan N Producer: 20040628 In: Journal of clinical hypertension (Greenwich, Conn.) vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. [electronic resource] by Oparil, Suzanne Davis, Barry R Cushman, William C Ford, Charles E Furberg, Curt D Habib, Gabriel B Haywood, L Julian Margolis, Karen Probstfield, Jeffrey L Whelton, Paul K Wright, Jackson T Producer: 20130705 In: Hypertension (Dallas, Tex. : 1979) vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [electronic resource] by Papademetriou, Vasilios Piller, Linda B Ford, Charles E Gordon, David Hartney, Thomas J Geraci, Therese S Reisin, Efrain Sumner, Brian Montgomery Wong, Nathan D Nwachuku, Chuke Narayan, Puneet Haywood, Julian Habib, Gabriel Producer: 20040213 In: Journal of clinical hypertension (Greenwich, Conn.) vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. [electronic resource] by Piller, Linda B Simpson, Lara M Baraniuk, Sarah Habib, Gabriel B Rahman, Mahboob Basile, Jan N Dart, Richard A Ellsworth, Allan J Fendley, Herbert Probstfield, Jeffrey L Whelton, Paul K Davis, Barry R Producer: 20150615 In: Journal of general internal medicine vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. [electronic resource] by Yamal, José-Miguel Oparil, Suzanne Davis, Barry R Alderman, Michael H Calhoun, David A Cushman, William C Fendley, Herbert F Franklin, Stanley S Habib, Gabriel B Pressel, Sara L Probstfield, Jeffrey L Sastrasinh, Sithiporn Producer: 20150812 In: Journal of the American Society of Hypertension : JASH vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. [electronic resource] by Wright, Jackson T Dunn, J Kay Cutler, Jeffrey A Davis, Barry R Cushman, William C Ford, Charles E Haywood, L Julian Leenen, Frans H H Margolis, Karen L Papademetriou, Vasilios Probstfield, Jeffrey L Whelton, Paul K Habib, Gabriel B Producer: 20050411 In: JAMA vol. 293 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)